Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Par Pharmaceutical

Division of Endo International PLC
www.parpharm.com/generics.php

Latest From Par Pharmaceutical

Par Prepares To Offer First Orfadin Rival With Improved Storage

By being able to be stored at room temperature, Par’s first generic of Sobi’s Orfadin nitisinone capsules offer a competitive advantage over the reference brand.

Launches United States

Behind-The-Scenes Battles As Opioid MDL Jury Trial Nears

Expert witness "battle plan," requests for summary judgment, and squabble over DEA drug distribution data offer preview of the first US bellwether trial against opioid manufacturers, distributors and pharmacies.

 
Legal Issues Advertising, Marketing & Sales

Neuraxpharm Names Local Head As It Expands Into UK

Neuraxpharm has appointed Craig Bowen as general manager of its UK affiliate at the same time as the European central nervous system specialist has launched its first products in the UK market.

Strategy Appointments

Biogen Growth Continues, But Analysts Worry About Near-Term R&D Prospects

The biotech’s MS franchise led by Tecfidera grew strongly, while SMA therapy Spinraza dipped slightly, but Biogen maintains optimistic outlook amidst growing competition.

Sales & Earnings Commercial
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register